Tandem Diabetes Care, Inc. (TNDM) Reports Q3 Loss, Tops Revenue Estimates
Portfolio Pulse from
Tandem Diabetes Care, Inc. (TNDM) reported a Q3 loss of $0.36 per share, which was better than the Zacks Consensus Estimate of a $0.43 loss. This is an improvement from the $0.38 loss per share reported a year ago.
November 06, 2024 | 11:45 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Tandem Diabetes Care reported a Q3 loss of $0.36 per share, beating the expected loss of $0.43. This is an improvement from last year's $0.38 loss per share.
Tandem Diabetes Care's Q3 loss was smaller than expected, which is a positive indicator for investors. Beating earnings estimates often leads to a short-term increase in stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100